Shallis RM, Weiss JJ, Winer ES, Badar T, et al. Feasibility and safety of outpatient hypomethylating agent and venetoclax initiation with and without ramp-up for newly diagnosed acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leuk Lymphoma 2025 Apr 28:1-5. doi: 10.1080/10428194.2025.2496339.
PMID: 40294060